Screener
Summit Therapeutics SMMT Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 1,664 | 1,059 |
| Operating lease right-of-use assets | 19,398 | 20,616 |
| Goodwill | 1,965 | 2,001 |
| Other assets | 8,231 | 7,205 |
| Total assets | $647,856 | $751,182 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $27,549 | $20,292 |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's other non-current assets?
- Summit Therapeutics (SMMT) reported other non-current assets of $8.23M in Q1 2026.
- How has Summit Therapeutics's other non-current assets changed year-over-year?
- Summit Therapeutics's other non-current assets increased by 98.6% year-over-year, from $4.15M to $8.23M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Summit Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude